FibroBiologics (FBLG) Total Debt (2026)

FibroBiologics (FBLG) posted quarterly Total Debt of $124000.0 for Q2 2026, down 49.59% on a QoQ basis from $246000.0 in Q1 2026.

FibroBiologics (FBLG) Total Debt (2026) Analysis & Trends

FibroBiologics has reported Total Debt for 1 years, with the latest figure at $124000.0 in Q2 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Vertex Pharmaceuticals	140.22 Bn	132.37 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.29 Bn	78.30 Bn	3.93 Bn	1.99 Bn
3	Argenx Se	65.17 Bn	59.98 Bn	1.37 Bn	-
4	Moderna	61.38 Bn	56.24 Bn	52.00 Mn	591.00 Mn
5	BeOne Medicines	42.18 Bn	37.09 Bn	1.53 Bn	1.07 Bn
6	Alnylam Pharmaceuticals	30.99 Bn	27.68 Bn	992.69 Mn	-
7	BioNTech SE	28.45 Bn	10.05 Bn	668.28 Mn	770.36 Mn
8	Insmed	27.47 Bn	26.31 Bn	358.27 Mn	546.77 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	9.34 Bn
10	FibroBiologics	9.06 Mn	9.06 Mn	-	124,000.00

Download Data

Date	Value
Jun 30, 2026	124,000.00
Mar 31, 2026	246,000.00